C29 - Multiple Sclerosis Overview II: Clinical Advances
Event Time: | Saturday May 4, 2019 1:30 pm to 3:30 pm |
Topic(s): | MS and CNS Inflammatory Disease, Foundations in Clinical Neurology for APPs |
Director(s): | Scott Newsome DO, FAAN |
Description: | It is extremely important for clinicians treating MS to enhance their knowledge base about the changing landscape of the MS disease-modifying therapies (DMTs). Making treatment decisions for an individual MS patient is a daunting task and the individualized patient benefit-risk assessment becomes increasingly difficult as new therapies emerge. Furthermore, if these therapies become available, clinicians need to have a full understanding of their benefit-risk profiles. Faculty will review the efficacy and safety profiles of current and late-stage emerging MS DMTs. It is equally challenging to define what constitutes optimal and suboptimal response to DMTs for an individual patient. Moreover, it is critical for clinicians to be able to recognize short-term clinical and paraclinical factors that may help identify patients at high risk for long-term disability. Faculty will review key considerations in MS clinical practice to address the above challenges in both didactic and case-based formats. This program complements Multiple Sclerosis Overview I: Clinical Pearls, but covers independent topics. |
Completion Message: | Participants should feel more confident in prescribing and monitoring multiple sclerosis (MS) disease-modifying therapies (DMTs) as it relates to their efficacy and safety profiles, and develop a better understanding of key considerations in clinical practice; become familiar with late-stage DMTs that have a strong potential of getting approved for use in MS; and be able to recognize what factors put an MS patient at risk for long-term disability and when to consider switching therapies. |
CME Credits: | 2 |
Core Competencies: | Patient Care, Medical Knowledge |
Start/End Time | Title | Faculty |
---|---|---|
1:30 PM - 2:30 PM | The Expanding Armamentarium of Multiple Sclerosis Therapeutics | Scott Douglas Newsome DO, FAAN |
2:30 PM - 3:30 PM | Case-based Considerations in Clinical Practice for Multiple Sclerosis | Carrie Michelle Hersh DO, MSc |
Speaker | Disclosure |
---|---|
Carrie Michelle Hersh, DO, MSc | Dr. Hersh has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen Idec, Novartis, Teva, Genentech, Genzyme, and EMD Serono. Dr. Hersh has received research support from Biogen Idec and Genentech. |
Scott Douglas Newsome, DO, FAAN | Dr. Newsome has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen, Celgene, EMD Serono, Genentech, Gerson Lehrman Group, and Syntimmune. Dr. Newsome has received research support from Biogen, Genentech, Department of Defense, the National MS Society, and Patient-Centered Outcomes Research Institute. |
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
7:00 AM-9:00 AM |
---|
C1 -
What Do I Do Now?: Assessment and Management of Neuropsychiatric Symptoms in Neurocognitive Disorders
Daniel Kaufer MD, FAAN |
C3 -
Clinical EEG: Normal EEG, Normal Variants, and How to Avoid The Common Pitfall of Over-reading
Selim Benbadis MD, FAAN |
C7 -
Clinical Pearls in Autoimmune Neurology: Real World Cases
Stacey Clardy MD, PhD |
9:30 AM-11:30 AM |
C14 -
Child Neurology: Headache
Amy Gelfand MD |
C15 -
Clinical EEG: Focal, Diffuse, and Epileptiform Abnormalities in Adults
Katherine Noe MD, PhD, FAAN |
C16 -
Cerebrovascular Disease I: Prevention
Larry Goldstein MD, FAAN, FAHA |
C19 -
Multiple Sclerosis Overview I: Clinical Pearls
Mary Willis MD |
12:00 PM-4:00 PM |
C22 -
Resident Basic Science I: Neuropathology
J. Clay Goodman MD, FAAN |
1:30 PM-3:30 PM |
C27 -
Cerebrovascular Disease II: Update on Guidance-Based Diagnosis and Management of Hemorrhagic Stroke
Andrew Naidech MD, FAAN |
C34 -
Evaluating Tremor in the Office
Andres Deik Acosta Madiedo MD |
7:00 AM-9:00 AM |
---|
C247 -
What Do I Do Now?: Emergency and Inpatient Management of Migraine and Other Headache Disorders
Stephanie Nahas MD, FAAN |
C248 -
Multiple Sclerosis in the Trenches: Controversy and Consensus in Clinical Decision-Making
Aaron Miller MD, FAAN |
9:15 AM-11:30 AM |
Neurology Year in Review Plenary Session
Martinson Arnan MD |
1:00 PM-3:00 PM |
S56 -
MS Trials and Treatment
|
3:30 PM-4:30 PM |
C258 -
Education Blitz: Multiple Sclerosis
Stephen Krieger MD, FAAN |